Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02922777
Recruitment Status : Recruiting
First Posted : October 4, 2016
Last Update Posted : December 10, 2018
Sponsor:
Collaborators:
Texas Tech University Health Sciences Center
BerGenBio ASA
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2019
  Estimated Study Completion Date : May 2020